Ticker
ABVCCompany Name
ABVC BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 69.92M | $ 2.55M | $ 283.52K | $ 0 | -4.06% |
3/31/2025 | $ 17.78M | $ 1.38M | $ 304.13K | $ 0 | -9.49% |
12/31/2024 | $ 14.12M | $ 1.37M | $ 615.48K | $ 0 | -14.03% |
9/30/2024 | $ 7.15M | $ 1.27M | $ 213.08K | $ 0 | -20.79% |
6/30/2024 | $ 9.32M | $ 4.72M | $ -1.43M | $ 0 | -35.3% |
3/31/2024 | $ 11.61M | $ 3.85M | $ -1.46M | $ 0 | -20.57% |
12/31/2023 | $ 12.99M | $ 3.46M | $ 462.62K | $ 0 | -30.17% |
9/30/2023 | $ 9.04M | $ 3.23M | $ 352.51K | $ 0 | -39.58% |
6/30/2023 | $ 7.39M | $ 0 | $ 2.52M | $ 0 | -34.17% |
3/31/2023 | $ 25.8M | $ 3.66M | $ 2.56M | $ 0 | -24.11% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for ABVC BIOPHARMA INC is calculated as follows: (-1 * CF - Equity [ $ 0 ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 66.32M ]
(=) Shareholder Yield [ 0% ]
Minimum
Jun 30, 2022
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |